Targeting Human C-Type Lectin-Like Molecule-1 (CLL1) with a Bispecific Antibody for Acute Myeloid Leukemia Immunotherapy

Acute myeloid leukemia (AML), the most common acute adult leukemia and the second most common pediatric leukemia, still has a poor prognosis. Human C-type lectin-like molecule-1 (CLL1) is a recently identified myeloid lineage restricted cell surface marker, which is overexpressed in over 90% of AML...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Angew Chem Int Ed Engl
Egile Nagusiak: Lu, Hua, Zhou, Quan, Deshmukh, Vishal, Phull, Hardeep, Ma, Jennifer, Tardif, Virginie, Naik, Rahul R., Bouvard, Claire, Zhang, Yong, Choi, Seihyun, Lawson, Brian R., Zhu, Shoutian, Kim, Chan Hyuk, Schultz, Peter G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4280064/
https://ncbi.nlm.nih.gov/pubmed/25056598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201405353
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak